Key Hearing Loss Disease Treatment Market Players:
- Bayer
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Cochlear Ltd
- Demant A/S
- Eargo, Inc
- GlaxoSmithKline
- GN Store Nord A/S
- Pfizer
- Sonova Holding AG
- Starkey
- WS Audiology
The companies establish, design, and release hearing aids, cochlear implants, as well as other types of auditory devices play an important role in improving the quality of life for people across the world affected by hearing impairment. The companies continue researching and developing in pursuit of making hearing aids more complex, featuring AI, clearer and better sound quality, and increased comfort for the user. For instance, in April 2021, Rinri Therapeutics raised a total of USD 13.2 million from investors and the UK Future Fund to further develop its cutting-edge stem cell therapy for the restoration of hearing loss. Companies also invest in better software for more effective diagnostics. Hence, these companies not only add value to the outcomes of the patient but also reduce the stigma associated with loss of hearing by focusing on aftercare services and collaborating with healthcare providers. The eminent hearing loss disease treatment market players are:
